Novartis AG NVS
Analyst Consensus
Price Objectif
Analyst historical
| Analyst | Entreprise | Price during analysis | Target price | Potential gain | Publication date |
|---|---|---|---|---|---|
| Wan Nurhayati | CFRA | 123.33 $ | 126 $ | 2.67 % | 29/10/2025 |
| Etzer Darout | BMO Capital | 109.91 $ | 120 $ | 10.09 % | 30/10/2024 |
| James Quigley | Goldman Sachs | 119.38 $ | 121 $ | 1.62 % | 05/09/2024 |
| Etzer Darout | BMO Capital | 106.13 $ | 118 $ | 11.87 % | 19/07/2024 |
| Wan Nurhayati | CFRA | 97.27 $ | 108 $ | 10.73 % | 23/04/2024 |